EGFR-HER2 inhibitor AZD3759, Purity ≥98%

Cat. No.: X24-05-ZQ657

EGFR-HER2 inhibitor AZD3759, Purity ≥98%

Synonym: 1626387-80-1; AZD 3759; EGFR-HER2 inhibitor

  • CAS Number: 1626387-80-1
  • Compound CID: 78209992
Product Size
10 mg; 25 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
AZD3759, soluble in DMSO and warmed ethanol and insoluble in water, is a compound that blocks the activity of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2), both of which are involved in driving the growth and proliferation of certain types of cancer cells. It targets EGFR (exon 19Del), EGFR (L858R), and EGFR (WT).
Molecular Weight
459.9
Molecular Formula
C22H23ClFN5O3
Targets
EGFR (exon 19Del): 0.2 nM; EGFR (L858R): 0.2 nM; EGFR (WT): 0.3 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 80 mg/mL (173.94 mM); Water: Insoluble; Warmed ethanol: 18 mg/mL (39.13 mM)
Identity
Confirmed by NMR/HPLC/MS.
Applications
AZD3759 is investigated for its selective inhibition of EGFR and its implications in treating brain metastases from non-small cell lung cancer.
Related Products

Thanksgiving 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0